Clinical Trials Directory

Trials / Completed

CompletedNCT00956917

Comparison Study for Bioelectrical Impedance Device to Measure Human Body Composition

Comparison of Impedance Components and Estimated Body Composition Variables Determined by Using Bioelectrical Impedance Devices Manufactured by Akern SRL and RJL Systems

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
109 (actual)
Sponsor
Akern USA LLC · Industry
Sex
All
Age
16 Years – 90 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to determine if the ElectroFluidGraph(tm) (EFG) impedance analyzer is comparable to a predicate device in measuring human body composition.

Detailed description

The purpose of this study is to determine if the ElectroFluidGraph(tm) (EFG) impedance analyzer is comparable to a predicate device in measuring human body composition under normal patient conditions. Specifically, the goal of this study is to compare impedance measurements (R and Xc) determined by using each bioelectrical impedance device and the estimated body compositional estimates \[total body water (TBW); fat-free mass (FFM); and fat mass (FM)\] calculated by using the same prediction equation (models) as the predicate device.

Conditions

Interventions

TypeNameDescription
DEVICEAkern USA EFGImpedance measurement device
DEVICERJL Impedance analyzerImpedance analyzer

Timeline

Start date
2009-05-01
Primary completion
2009-06-01
Completion
2009-06-01
First posted
2009-08-11
Last updated
2009-08-11

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT00956917. Inclusion in this directory is not an endorsement.